Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Shareholder Equity 2020–2023
Gain Therapeutics Inc. annual shareholder equity history from 2020 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Gain Therapeutics Inc. shareholder equity as of December 31, 2023: 12.6M, a 33.38% decrease year-over-year.
- Gain Therapeutics Inc. shareholder equity for 2023 were 12.6M, a 33.38% decrease from 2022.
- Gain Therapeutics Inc. shareholder equity for 2022 were 18.9M, a 45.78% decrease from 2021.
- Gain Therapeutics Inc. shareholder equity for 2021 were 34.8M, a 461.39% increase from 2020.
- Gain Therapeutics Inc. shareholder equity for 2020 were 6.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gain Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $13 |
| 2022 | $19 |
| 2021 | $35 |
| 2020 | $6 |
Gain Therapeutics Inc. Shareholder Equity — FAQ
Gain Therapeutics Inc. (GANX) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's shareholder equity history?
The chart and table above show Gain Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.